Brief: TransCode Therapeutics Reports Q2 2022 Results
Aug 15 (Reuters) - Transcode Therapeutics Inc RNAZ.O :
* TRANSCODE THERAPEUTICS REPORTS SECOND QUARTER 2022
RESULTS;
PROVIDES BUSINESS UPDATE
* TRANSCODE THERAPEUTICS -EXPECTS CASH OF $13.4 MILLION AS
OF JUNE
30, IS SUFFICIENT TO FUND PLANNED OPERATIONS INTO Q1 2023
Source text for Eikon: ID:nGNX6y1ZQH
Further company coverage: RNAZ.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Transcode Therapeutics
See all newsBrief: TransCode Therapeutics Appoints John Tattory As Interim CFO
Brief: Transcode Therapeutics Appoints Dr. Anna Moore As Chair Of Scientific Advisory Board
Brief: Transcode Therapeutics Inc - Enters Exclusive License Agreement With Unleash
Brief: Transcode Therapeutics Ttx-Mc138 Phase 2A Clinical Trial Expected In First Half Of 2026
Brief: Transcode Therapeutics Expands Leadership With Appointment Of Jack E. Stover To Board Of Directors